BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8137681)

  • 1. The predictive value of microalbuminuria in IDDM. A five-year follow-up study.
    Almdal T; Nörgaard K; Feldt-Rasmussen B; Deckert T
    Diabetes Care; 1994 Feb; 17(2):120-5. PubMed ID: 8137681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
    Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
    Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
    Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study.
    Mathiesen ER; Rønn B; Storm B; Foght H; Deckert T
    Diabet Med; 1995 Jun; 12(6):482-7. PubMed ID: 7648820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H; Jensen JS; Jensen T; Deckert T
    J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
    Yokoyama H; Jensen JS; Myrup B; Mathiesen ER; Rønn B; Deckert T
    Diabetes Care; 1996 May; 19(5):435-40. PubMed ID: 8732705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria development in short-term IDDM.
    González-Clemente JM; Esmatjes E; Navarro P; Ercilla G; Casamitjana R; Rios M; Levy I; Gomis R; Vilardell E
    Diabetes Res Clin Pract; 1994 May; 24(1):15-23. PubMed ID: 7924882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
    BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unchanged incidence of diabetic nephropathy in IDDM patients.
    Rossing P; Rossing K; Jacobsen P; Parving HH
    Diabetes; 1995 Jul; 44(7):739-43. PubMed ID: 7789641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.
    Rossing P; Hougaard P; Parving HH
    Diabetes Care; 2002 May; 25(5):859-64. PubMed ID: 11978681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'.
    Esmatjes E; De Alvaro F;
    Diabetes Res Clin Pract; 2002 Jul; 57(1):35-43. PubMed ID: 12007728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo Perin P;
    Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.
    Forsblom CM; Groop PH; Ekstrand A; Groop LC
    BMJ; 1992 Oct; 305(6861):1051-3. PubMed ID: 1467683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of microalbuminuria in type 1 diabetic patients (IDDM) in the Antwerp University Hospital.
    Bouten A; Engelen W; De Leeuw I
    Acta Clin Belg; 1996; 51(4):231-6. PubMed ID: 8858888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.